October 25, 2025
Article
Exercise, as an expert explained to CURE, can have a significant positive impact on long-term outcomes for patients with cancer.
October 24, 2025
The FDA has approved Revuforj for relapsed or refractory acute myeloid leukemia with an NPM1 mutation.
Video
CURE spoke with Dr. Surbhi Sidana about the recently approved antibody-drug conjugate Blenrep for multiple myeloma.
The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.
Anemia Management in Myelofibrosis: Survival and Quality of Life
Simple Ways for Patients With Cancer to Start Exercising
Finding Credible Voices in the Lynch Syndrome Community
Understanding Your Stage 2 Lymphoma Diagnosis